Specialty pharma, sold by reps who can talk both clinical and access.
Specialty pharma conversions happen when the prescribing physician understands the clinical case and the access pathway in the same conversation. Solara reps bring both — and they are non-promotional within FDA cleared indications.
Why specialty pharma needs a different rep
Selling specialty pharma is selling a system: indication, payer pathway, hub services, patient-assistance program, and ongoing access management. A rep who can only talk clinical fails the practice. A rep who can only talk access fails the physician. Solara reps are trained on both, kept current on label changes, and held to compliant promotional behavior by the platform.
What changes when specialty pharma runs on the Solara network.
Clinical and access fluency in one rep
Reps are trained on indication, mechanism, and payer-pathway specifics for each product they carry. The conversation moves from clinical fit to access in the same call.
Compliance built into the call
Promotional materials are platform-controlled. Reps work from FDA-approved messaging only. Compliance review is a build-time step, not a post-hoc audit.
Hub and patient-assistance program coordination
Reps connect prescribing practices to the manufacturer hub and route enrollment friction back to the manufacturer in real time. Patient drop-off at access is the largest preventable churn driver — we instrument for it.
Specialties served by this category.
- ·Specialty internal medicine
- ·Rheumatology
- ·Oncology and hematology
- ·Neurology
- ·Endocrinology
- ·Hepatology and gastroenterology
Who Solara distributes for in this category.
- ·Specialty pharmaceuticals (autoimmune, oncology, neurology, rare disease)
- ·Biotech and biologics
- ·Buy-and-bill products
- ·Specialty-pharmacy distributed products
What manufacturers ask before they pilot.
- Are Solara reps trained on FDA promotional compliance?
- Yes. All promotional materials are platform-controlled, current to the latest approved label, and reviewed by manufacturer regulatory before deployment. Reps work only from approved messaging — off-label promotion is a contractual and platform-level violation.
- Does Solara handle Sunshine Act / Open Payments tracking?
- The platform logs every rep-physician interaction, sample distribution, and meal/event so manufacturers have audit-ready data. Manufacturer-of-record reporting (CMS Open Payments submissions) remains with the manufacturer.
- Can Solara reps support patient-assistance program enrollment?
- Reps facilitate the hand-off between prescribing practice and the manufacturer hub or specialty pharmacy. They do not directly enroll patients. Hub services remain with the manufacturer.
- How does Solara handle MSL or peer-to-peer scientific exchange?
- Solara is a commercial-channel partner. Medical Affairs and MSL functions remain with the manufacturer. Where peer-to-peer programs are part of a launch, Solara reps coordinate logistics — speaker engagement, attendee management — without participating in the scientific content itself.
Pilot a specialty pharma territory in 30 days.
Book a working session — we’ll load your target sub-segment into Solara live, walk through territory coverage, and propose a pilot scope.